Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cupping Helps Relieve Carpal Tunnel Syndrome Symptoms

By HospiMedica International staff writers
Posted on 19 Aug 2009
An external healing method called cupping helps relieve pain caused by carpal tunnel syndrome (CTS), according to a new study.

Researchers at Immanuel Hospital (Berlin, Germany) conducted an open randomized trial that examined the effectiveness of cupping, a traditional method of treating musculoskeletal pain used in Asia, the Middle East, Europe, and parts of Africa, in patients with CTS. More...
The researchers randomly assigned 52 outpatient participants to two equal groups. The 26 patients in the study group were treated with a single application of wet cupping glasses applied to the skin in the shoulder-neck area, following 5 to 10 skin punctures with a sterile lancet; a partial vacuum was then created using either electromechanical or manual suction within the cupping glass after it was applied to the skin. The 26 control patients received a single local application of heat within the region overlying the trapezius muscle.

The researchers found that the severity of CTS symptoms was reduced significantly in the cupping group on day 7 after the application, compared to the control group. Significant treatment effects were also found for the Levine CTS-score, neck pain, functional disability (DASH-Score), and physical quality of life. The treatment was safe and well tolerated in all patients. The study was published in the June 2009 issue of the Journal of Pain.

"Cupping is applied to defined zones of the shoulder triangle which are connective tissue zones at the shoulder-neck region,” said lead author Professor Andreas Michlson, M.D., of the department of internal and complementary medicine. "The technique is believed to increase microcirculation to help relieve [carpal tunnel syndrome] symptoms.”

CTS (also known as median neuropathy) is a condition in which the median nerve is compressed at the wrist, leading to paresthesias, numbness, and muscle weakness in the hand. Most cases of CTS are idiopathic; genetic factors determine most of the risk, and the role of arm use and other environmental factors is disputed. The role of medications, including corticosteroid injection into the carpal canal, is also unclear. Surgery to cut the transverse carpal ligament is effective at relieving symptoms and preventing ongoing nerve damage, but established nerve dysfunction in the form of static numbness, atrophy, or weakness are usually permanent and do not respond predictably to surgery.

Related Links:

Immanuel Hospital




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.